Related Experiment Videos
Neuroleptic drug utilisation for acute schizophrenia
1Department of Psychiatry, School of Medical Sciences, Kelantan, Malaysia.
Singapore Medical Journal
|December 1, 1996
Summary
This study found that 400-600 mg of chlorpromazine daily, or equivalent, effectively treated acute schizophrenia in inpatients. Doses varied by drug potency, administration route, and patient
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Schizophrenia treatment requires careful neuroleptic drug management.
- Understanding typical dosage patterns is crucial for effective acute psychosis care.
Purpose of the Study:
- To determine neuroleptic drug dosage and utilization patterns for acute schizophrenia.
- To analyze prescribing habits in a general psychiatric ward setting.
Main Methods:
- Uncontrolled study of 112 schizophrenic inpatients.
- Analysis of socio-demographic variables, neuroleptic type, and peak daily doses.
- Calculation of chlorpromazine equivalents for dose comparison.
Main Results:
- Chlorpromazine was the most frequently prescribed neuroleptic.
- A mean daily dose equivalent to 537 mg of chlorpromazine was required.
- 400-600 mg/day chlorpromazine equivalent was generally sufficient for acute psychosis.
- Lower potency drugs were used in lower doses than high potency drugs.
- Depot preparations were associated with higher doses than oral medications.
- Neuroleptic doses correlated significantly with length of hospital admission.
Conclusions:
- A specific dosage range of neuroleptics is effective for acute schizophrenia.
- Prescribing patterns are influenced by drug properties and administration methods.
- Dosage optimization is linked to patient factors like admission duration.